Pavani Chalasani, MD, University of Arizona Cancer Center

Articles by Pavani Chalasani, MD, University of Arizona Cancer Center

Metastatic Triple-Negative Breast Cancer

ByWilliam J. Gradishar, MD, Northwestern University,Priyanka Sharma, MD, University of Kansas Cancer Center,Pavani Chalasani, MD, University of Arizona Cancer Center

January 27th 2021

Metastatic Hormone Epidermal Growth Factor Receptor 2-Positive Breast Cancer

ByWilliam J. Gradishar, MD, Northwestern University,Priyanka Sharma, MD, University of Kansas Cancer Center,Pavani Chalasani, MD, University of Arizona Cancer Center

January 27th 2021

Metastatic Hormone-Receptor Positive Breast Cancer

ByWilliam J. Gradishar, MD, Northwestern University,Priyanka Sharma, MD, University of Kansas Cancer Center,Pavani Chalasani, MD, University of Arizona Cancer Center

January 27th 2021

Latest Updated Articles

Metastatic Hormone Epidermal Growth Factor Receptor 2-Positive Breast Cancer
January 27th 2021
Metastatic Triple-Negative Breast Cancer
January 27th 2021
Metastatic Hormone-Receptor Positive Breast Cancer
January 27th 2021

Trending on OncLive

FDA Approves Pirtobrutinib for Previously Untreated CLL/SLL

The OncFive: Top Oncology Articles for the Week of 9/27/2026

AUA Releases Guideline Amendment for NMIBC

Daraxonrasib Approval Signals a New Era for RAS-Targeted Therapy in Pancreatic Cancer

FLORA-2 Updates at World Lung: Biomarker Analysis, Safety Follow-Up, and ctDNA Monitoring